Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey

Celik S., KIZILAY F., YÖRÜKOĞLU K., Ozen H., AKDOĞAN B., İZOL V., ...Daha Fazla

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, cilt.20, sa.1, ss.19-25, 2021 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/uob.galenos.2020.1677
  • Dergi Adı: UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.19-25
  • Anahtar Kelimeler: Prostate cancer, radical prostatectomy, clinically insignificant prostate cancer, Epstein criteria, 12-core prostate biopsy scheme, PERINEURAL INVASION, ACTIVE SURVEILLANCE, NEEDLE-BIOPSY, ADENOCARCINOMA, STAGE, CANDIDATES, OUTCOMES, UPDATE, EXTENT, MEN
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study is to investigate the relevance of the Epstein criteria for the 12-core transrectal prostate biopsy (TRUS-Bx) scheme with the evaluation of clinicopathologic data recorded in the Urologic Cancer Database - Prostate (UroCaD-P), Urooncology Association, Turkey (UOAT).